About us

History



History


2022


08
2022 Post-TIPS Program('22~'24)
2022 Korea Drug Development Project('22~'24)

2021


06
Master Collaboration Agreement contract with Pinotbio Co., Ltd.
02
Signed MOU with Medirita Co., Ltd.

2020


11
SME Technological Innovation & Development Progrm ('20~'22)
09
Changed Company Name(Repigen Inc. → ProEn Therapeutics Inc.)
08
Series A Funding (KRW 7.5 billion)

2019


07
License Out agreement & Equity Investment Contract with Ahngook pham.(domestic pharmaceutical company)
03
Acquired corporate laboratory cetification

2017


11
2017 TIPS Program('17~'19)

2015


08
Foundation('15.08)

상호명  주식회사 프로엔테라퓨틱스  |  대표자  이일한

전화번호  031-759-8788  |  팩스번호  031-759-8850

이메일  proen@proentherapeutics.com

판교지사  경기도 성남시 수정구 청계산로 686 반도아이비밸리 301호

대전본사  대전광역시 유성구 테크노4로 17 대덕비즈센터 B동 204호

Copyright 2021. ProEn Therapeutics Inc. All Rights Reserved.


ProEn Therapeutics Inc.

TEL  +(82)-31-759-8788  |  FAX  +(82)-31-759-8850  |  E-mail  proen@proentherapeutics.com

Address  Pangyo Branch #301, 686, Cheonggyesan-ro, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea

Copyright 2021. ProEn Therapeutics Inc. All Rights Reserved.